BodyB. A., FromtlingR. A., ShadomyS., ShadomyJ. H.: In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents. Eur. J. Clin. Microbiol., 2; 230–234 (1983).
2.
BolognaM., VaggiL., MartiniE., TorneiE.: Norfloxacin in the treatment of urinary tract infections. Eur. J. Chemother. Antib., 3; 41–46 (1983).
3.
CorradoJ. L., CherubinC. E., ShulmanM.: The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria. J. Antimicrob. Chemother., 11; 369–376 (1983).
4.
CorradoM., SabbajJ., BrownK., StrubleW., CahanG.: The safety profile of norfloxacin during clinical trials. Proc. 13th Intern. Congr. Chemoth., Vienna 1983, SS 4.6/9, part.38: 51–53 (1983).
5.
EandiM., VianoI., Di NolaF., LeoneL., GenazzaniE.: Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage. Eur. J. Clin. Microbiol., 2; 253–259 (1983).
6.
FabioU., ProvvisionatoC. A., TampieriA., QuaglioG. P.: Azione antibatterica in vitro della norfloxacina. Giorn. Ital. Chemioter., 30; 55–59 (1983).
7.
NorrbyS. R.: Pharmacokinetics of norfloxacin: clinical implications. Eur. J. Chemother. Antib., 3; 19–25 (1983).
8.
SabbajJ., HoaglandV. L., CorradoM. L.: Clinical experience with norfloxacin in the treatment of urinary tract infection. Proc. 13th Intern. Chemoth., Vienna 1983, SS 4.6/9, part.38: 31–38 (1983).